Skip to main content
Clinical Trials/NCT01927302
NCT01927302
Completed
N/A

The Center for the Neurobiology of Language Recovery (CNLR)

Northwestern University4 sites in 1 country90 target enrollmentApril 2013

Overview

Phase
N/A
Intervention
Not specified
Conditions
Aphasia
Sponsor
Northwestern University
Enrollment
90
Locations
4
Primary Endpoint
Change in language and cognitive abilities as a result of treatment
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The purpose of this study is to investigate the effects of treatment for specific language deficits in people with aphasia. In addition to language and cognitive measures, changes in brain function will also be gathered before and after the treatment is administered in order to track any changes resulting from receiving treatment.

Detailed Description

Naming Impairments (Anomia): The labs of Dr. Swathi Kiran (Boston University) and Dr. David Caplan (Harvard University, Massachusetts General Hospital) will be studying language recovery in adults with anomia (naming impairments) following a stroke. Participants will receive treatment focusing on the semantic features of common objects (e.g., that birds can fly). The study will examine how naming and other language abilities change in response to treatment, as well as how the brain changes, as measured by magnetic resonance imaging (MRI) and other techniques. Spelling/Writing Impairments (Dysgraphia): At Johns Hopkins University, the lab of Dr. Brenda Rapp will investigate the neurobiology of language recovery in individuals with dysgraphia (spelling/writing impairments) resulting from a stroke. In this study, treatment will focus on improving spelling ability. The study will examine how spelling and other language abilities change in response to treatment, as well as how the brain changes, as measured by magnetic resonance imaging (MRI) and other techniques. Deficits in Sentence Comprehension \& Production: Dr. Cynthia Thompson's lab at Northwestern University will investigate language recovery in individuals with deficits in sentence production and comprehension. Treatment focuses on production and comprehension of complex sentences. At baseline (week 0) and after the treatment period (at week 12), participants take part in language, eye-tracking, and MRI testing, in order to learn how the processing of language, as well as brain function, changes as a result of treatment.

Registry
clinicaltrials.gov
Start Date
April 2013
End Date
March 27, 2019
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Cynthia K Thompson

Ralph and Jean Sundin Professor of Communication Sciences

Northwestern University

Eligibility Criteria

Inclusion Criteria

  • Aphasia following a stroke
  • Stoke was at least 1 year ago
  • Medically stable
  • Right-handed
  • Normal or 'corrected to normal' vision and hearing
  • English as primary language
  • At least a high school education

Exclusion Criteria

  • History of neurological disease, head trauma, psychiatric disorders, alcoholism, or developmental speech, language, or learning disabilities

Outcomes

Primary Outcomes

Change in language and cognitive abilities as a result of treatment

Time Frame: week 0 to week 12

Standard and non-standard measures of language and cognitive abilities will be gathered at baseline (week 0) to see if language deficits improve after treatment is administered (week 12).

Secondary Outcomes

  • Composite change in brain function as a result of treatment(week 0 to week 12)
  • Maintenance of composite changes in brain function as a result of treatment(week 12 to week 24)
  • Maintenance of language and cognitive abilities as a result of treatment(week 12 to week 24)

Study Sites (4)

Loading locations...

Similar Trials